Related Experiment Video
Updated: Aug 13, 2026
Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells
Published on: November 12, 2015
E1A genes of adenovirus type 2 and type 5 are expressed at different levels
1Institut für Virologie, Klinikum der Philipps-Universität Marburg, Marburg, Germany.
Abstract:
Adenoviruses are an extensively studied system for modeling oncogenesis and for experimental cancer therapy. The most commonly analyzed virus types are 2 and 5, and little distinction has been made between them in past studies. Adenoviruses used for therapeutic purposes are frequently hybrids between these types, including the prototype dl1520/Onyx015. We tested the replication of the wild-type viruses WtD (a hybrid of the type 2 E1 region and type 5) and dl309 (type 5) in comparison with the mutants dl1520 (hybrid) and dl338 (type 5), the latter two lacking part of the E1B-55 kDa coding region. We found that the hybrid viruses replicated with considerably lower efficiency than their type 5 counterparts in H1299 cells (dl309:WtD = 3-4, dl338:dl1520 > 10). Moreover, adenovirus type 2 E1A expression from the hybrid viruses was strongly reduced in comparison to adenovirus type 5 E1A, as revealed by immunoblot analysis and RT-PCR, providing a potential explanation for the differences in virus yield. Differential E1A expression levels need to be taken into account for the construction of effective therapeutic viruses and when studying viral transformation.
Insights
Hybrid adenoviruses showed lower replication efficiency than type 5 counterparts due to reduced adenovirus type 2 E1A expression. These findings impact the development of effective therapeutic adenoviruses and oncogenesis models.
Area of Science:
- Virology
- Oncology
- Molecular Biology
Background:
- Adenoviruses are crucial models for studying cancer development and therapeutic strategies.
- Adenovirus types 2 and 5 are commonly studied, with hybrids frequently used in therapy.
- Limited distinction between types 2 and 5 has been made in prior research.
Purpose of the Study:
- To compare the replication efficiency of wild-type and mutant adenoviruses.
- To investigate the role of E1A expression in adenovirus replication and oncogenesis.
- To inform the design of effective therapeutic adenoviruses and cancer models.
Main Methods:
- Replication assays of wild-type (WtD, dl309) and mutant (dl1520, dl338) adenoviruses in H1299 cells.
- Immunoblot analysis to assess viral protein expression.
- Reverse transcription PCR (RT-PCR) to quantify viral gene expression.
Main Results:
- Hybrid adenoviruses exhibited significantly lower replication efficiency compared to type 5 counterparts.
- Adenovirus type 2 E1A expression was markedly reduced in hybrid viruses versus type 5.
- Reduced E1A expression correlates with lower virus yield, offering an explanation for replication differences.
Conclusions:
- Differential E1A expression levels are critical for adenovirus replication and transformation.
- Findings necessitate consideration of E1A expression in constructing therapeutic adenoviruses.
- Understanding these differences is vital for advancing cancer therapy and oncogenesis research.
